A share price of Procept BioRobotics Corp [PRCT] is currently trading at $79.34, down -1.16%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The PRCT shares have gain 22.67% over the last week, with a monthly amount glided 23.20%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Procept BioRobotics Corp [NASDAQ: PRCT] stock has seen the most recent analyst activity on August 11, 2023, when Piper Sandler initiated its Overweight rating and assigned the stock a price target of $42. On October 31, 2022, BTIG Research initiated with a Neutral rating. Truist started tracking the stock assigning a Buy rating and suggested a price target of $58 on October 25, 2022. Wells Fargo initiated its recommendation with a Overweight and recommended $49 as its price target on September 02, 2022. KeyBanc Capital Markets started tracking with a Overweight rating for this stock on July 15, 2022, and assigned it a price target of $47. In a note dated June 23, 2022, B. Riley Securities initiated an Buy rating and provided a target price of $53 on this stock.
Procept BioRobotics Corp experienced fluctuations in its stock price throughout the past year between $24.83 and $85.81. Currently, Wall Street analysts expect the stock to reach $67.67 within the next 12 months. Procept BioRobotics Corp [NASDAQ: PRCT] shares were valued at $79.34 at the most recent close of the market. An investor can expect a potential drop of -14.71% based on the average PRCT price forecast.
Analyzing the PRCT fundamentals
Trailing Twelve Months sales for Procept BioRobotics Corp [NASDAQ:PRCT] were 176.57M which represents 61.17% growth. Gross Profit Margin for this corporation currently stands at 0.53% with Operating Profit Margin at -0.62%, Pretax Profit Margin comes in at -0.59%, and Net Profit Margin reading is -0.59%. To continue investigating profitability, this company’s Return on Assets is posted at -0.28, Equity is -0.38 and Total Capital is -0.33. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.21.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 76.47 points at the first support level, and at 73.61 for the second support level. However, for the 1st resistance point, the stock is sitting at 82.40, and for the 2nd resistance point, it is at 85.47.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Procept BioRobotics Corp [NASDAQ:PRCT] is 7.51. As well, the Quick Ratio is 6.49, while the Cash Ratio is 5.0. Considering the valuation of this stock, the price to sales ratio is 23.33, the price to book ratio is 16.35.
Transactions by insiders
Recent insider trading involved Nouri Alaleh, EVP, CLO, CORP. SEC., that happened on Jun 17 ’24 when 10000.0 shares were sold. EVP, Chief Comm. Officer, Shiblaq Hisham completed a deal on Jun 10 ’24 to sell 26046.0 shares. Meanwhile, Director Krummel Thomas M sold 20000.0 shares on May 01 ’24.
